Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ceftriaxone Prophylaxis Timing in Elective Cesarean Section
NCT02742948Phase 2Unknown
- Sponsor
- Cairo University
- Start
- Apr 2016
- Primary completion
- Aug 2016
- Modality
- Reversible Covalent Inhibitors
01
Overview
Phase 2, randomised, double-blind trial of ceftriaxone in endometritis, Wound infection (WI), urinary tract infection (UTI) and 1 more, sponsored by Cairo University. Primary endpoint: Postoperative Endometritis at 4 weeks. Status: unknown.
02
Drugs
ceftriaxone
03
Conditions
endometritisWound infection (WI)urinary tract infection (UTI)neonatal sepsis
Beyond the preview
Go deeper on NCT02742948.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02742948.